$VRNS
VARONIS SYSTEMS INC Stock $vrns

$vrns Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000162828023014872 Filed on May 02, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$115.4M	$107.3M	$96.26M
YoY Change	3.56%	11.5%	28.72%
Cost Of Revenue	$17.39M	$17.64M	$17.81M
YoY Change	-2.32%	-0.97%	32.09%
Gross Profit	$98.03M	$89.70M	$78.45M
YoY Change	4.68%	14.33%	27.97%
Gross Profit Margin	84.94%	83.57%	81.5%
Selling, General & Admin	$91.60M	$88.08M	$82.97M
YoY Change	6.02%	6.17%	27.02%
% of Gross Profit	93.44%	98.2%	105.76%
Research & Development	$46.14M	$44.73M	$43.57M
YoY Change	2.97%	2.67%	44.93%
% of Gross Profit	47.07%	49.87%	55.54%
Depreciation & Amortization	$2.916M	$2.891M	$2.679M
YoY Change	16.73%	7.91%	14.05%
% of Gross Profit	2.97%	3.22%	3.41%
Operating Expenses	$137.7M	$132.8M	$126.5M
YoY Change	4.98%	4.96%	32.67%
Operating Profit	-$39.72M	-$43.12M	-$48.09M
YoY Change	5.72%	-10.33%	41.12%
Interest Expense	$8.465M	$7.773M	$736.0K
YoY Change	184.44%	956.11%	-172.16%
% of Operating Profit
Other Income/Expense, Net	$8.465M	$7.773M	$736.0K
YoY Change	184.44%	956.11%	-172.02%
Pretax Income	-$31.25M	-$35.34M	-$47.35M
YoY Change	-9.66%	-25.36%	34.91%
Income Tax	$7.446M	$2.961M	$1.414M
% Of Pretax Income
Net Earnings	-$38.70M	-$38.30M	-$48.76M
YoY Change	6.63%	-21.45%	36.76%
Net Earnings / Revenue	-33.53%	-35.69%	-50.66%
Basic Earnings Per Share	-$0.35	-$0.35	-$0.45
Diluted Earnings Per Share	-$0.35	-$0.35	-$0.45
COMMON SHARES
Basic Shares Outstanding	109.7M shares	107.6M shares	108.2M shares
Diluted Shares Outstanding	109.7M shares	108.4M shares	108.2M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$753.8M	$756.3M	$804.1M
YoY Change	-4.44%	-5.95%	-2.42%
Cash & Equivalents	$399.2M	$248.6M	$775.7M
Short-Term Investments	$354.6M	$507.7M	$28.37M
Other Short-Term Assets	$47.90M	$44.38M	$35.81M
YoY Change	41.3%	23.93%	45.58%
Inventory
Prepaid Expenses
Receivables	$103.7M	$75.39M	$63.60M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$905.3M	$876.0M	$903.5M
YoY Change	-0.14%	-3.04%	0.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$90.52M	$37.64M	$39.50M
YoY Change	128.38%	-4.69%	9.92%
Goodwill	$23.14M	$23.14M	$23.14M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$2.025M	$2.406M	$3.931M
YoY Change	-42.96%	-38.79%	-28.03%
Long-Term Investments
YoY Change
Other Assets	$15.89M	$16.40M	$20.14M
YoY Change	-15.77%	-18.58%	3.59%
Total Long-Term Assets	$131.6M	$135.3M	$148.1M
YoY Change	-9.7%	-8.63%	7.31%
TOTAL ASSETS
Total Short-Term Assets	$905.3M	$876.0M	$903.5M
Total Long-Term Assets	$131.6M	$135.3M	$148.1M
Total Assets	$1.037B	$1.011B	$1.052B
YoY Change	-1.46%	-3.83%	1.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$680.0K	$708.0K	$4.771M
YoY Change	-85.71%	-85.16%	648.98%
Accrued Expenses	$123.3M	$107.3M	$92.56M
YoY Change	16.6%	15.97%	6.39%
Deferred Revenue	$130.7M	$109.3M	$98.76M
YoY Change	32.89%	10.67%	7.82%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$254.8M	$217.3M	$196.1M
YoY Change	21.94%	10.84%	9.39%
LONG-TERM LIABILITIES
Long-Term Debt	$249.7M	$249.3M	$247.8M
YoY Change	0.6%	0.6%	12.61%
Other Long-Term Liabilities	$61.72M	$5.985M	$3.680M
YoY Change	1280.1%	62.64%	12.4%
Total Long-Term Liabilities	$311.4M	$312.7M	$319.7M
YoY Change	-1.74%	-2.19%	14.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$254.8M	$217.3M	$196.1M
Total Long-Term Liabilities	$311.4M	$312.7M	$319.7M
Total Liabilities	$566.2M	$530.0M	$515.8M
YoY Change	7.67%	2.76%	12.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$620.5M	-$581.8M	-$467.7M
YoY Change	23.11%	24.39%	35.02%
Common Stock	$110.0K	$110.0K	$110.0K
YoY Change	0.0%	0.0%	3.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$470.7M	$481.3M	$535.8M
YoY Change
Total Liabilities & Shareholders Equity	$1.037B	$1.011B	$1.052B
YoY Change	-1.46%	-3.83%	1.33%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$38.70M	-$38.30M	-$48.76M
YoY Change	6.63%	-21.45%	36.76%
Depreciation, Depletion And Amortization	$2.916M	$2.891M	$2.679M
YoY Change	16.73%	7.91%	14.05%
Cash From Operating Activities	$5.806M	$36.83M	$24.54M
YoY Change	-140.13%	50.07%	20.4%
INVESTING ACTIVITIES
Capital Expenditures	$1.493M	$1.110M	$3.495M
YoY Change	-156.57%	-68.24%	213.17%
Acquisitions
YoY Change
Other Investing Activities	$153.9M	-$141.4M	-$28.38M
YoY Change	-2929.36%	398.34%	660.72%
Cash From Investing Activities	$152.4M	-$142.5M	-$31.87M
YoY Change	-1986.67%	347.18%	557.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-7.619M	-$13.53M	-$22.71M
YoY Change	761800.0%	-40.43%	-104.51%
NET CHANGE
Cash From Operating Activities	5.806M	$36.83M	$24.54M
Cash From Investing Activities	152.4M	-$142.5M	-$31.87M
Cash From Financing Activities	-7.619M	-$13.53M	-$22.71M
Net Change In Cash	150.6M	-$119.2M	-$30.04M
YoY Change	-767.99%	296.83%	-105.78%
FREE CASH FLOW
Cash From Operating Activities	$5.806M	$36.83M	$24.54M
Capital Expenditures	$1.493M	$1.110M	$3.495M
Free Cash Flow	$4.313M	$35.72M	$21.05M
YoY Change	-136.46%	69.72%	9.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001361113
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2023Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2023Q1	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2032-12-31
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y10M24D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y8M23D
CY2023Q1	vrns	Subsidiary Or Equity Method Investee Number SubsidiaryOrEquityMethodInvesteeNumber	12	subsidiary
CY2022Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	741000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y8M8D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y8M23D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y8M8D
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-36324
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	VARONIS SYSTEMS, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	57-1222280
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1250 Broadway, 28th Floor
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10001
CY2023Q1	dei	City Area Code CityAreaCode	877
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	292-8767
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	VRNS
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	109712572	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	248585000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	367800000	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	280835000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	236338000	usd
CY2023Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	226850000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	128350000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16400000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3431000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3453000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	75393000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	135979000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	44381000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	37190000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	876044000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	905657000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	55692000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	56772000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37643000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39043000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2406000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2788000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	23135000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	23135000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16337000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	135276000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	138075000	usd
CY2023Q1	us-gaap	Assets Assets	1011320000	usd
CY2022Q4	us-gaap	Assets Assets	1043732000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	708000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2962000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	107338000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	115231000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	109297000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	110550000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	217343000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	228743000	usd
CY2023Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	249339000	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	248963000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	55993000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	57627000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1382000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1503000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5985000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4771000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	312699000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	312864000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	109791863	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	109791863	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	107673052	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107673052	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	110000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	108000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14381000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-9557000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1077327000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1055048000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-581778000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-543474000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	481278000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	502125000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1011320000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1043732000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	107335000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	96261000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	17637000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	17809000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	89698000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	78452000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44732000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43570000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	68393000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	64787000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19689000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18180000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	132814000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	126537000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-43116000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-48085000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7773000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	736000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-35343000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-47349000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2961000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1414000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-38304000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-48763000	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108387402	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108387402	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108204960	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108204960	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-38304000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-48763000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	150000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-10000	usd
CY2023Q1	vrns	Other Comprehensive Income Loss Securities Availablefor Sale Gain Loss Netof Tax OtherComprehensiveIncomeLossSecuritiesAvailableforSaleGainLossNetofTax	6000	usd
CY2022Q1	vrns	Other Comprehensive Income Loss Securities Availablefor Sale Gain Loss Netof Tax OtherComprehensiveIncomeLossSecuritiesAvailableforSaleGainLossNetofTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	156000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-10000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-2332000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-2759000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	2648000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	420000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-4980000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-3179000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4824000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3189000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43128000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-51952000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	596593000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35998000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6111000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	28825000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-3179000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-10000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-48763000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	535778000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	502125000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35811000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5853000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	16864000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2519000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-4980000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	156000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-38304000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	481278000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-38304000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-48763000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2891000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2679000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	35811000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	35998000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	3462000	usd
CY2022Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	6120000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2367000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2326000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	376000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	370000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1293000	usd
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-60586000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-53575000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7236000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2575000	usd
CY2023Q1	vrns	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	3033000	usd
CY2022Q1	vrns	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	6942000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	589000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-359000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2254000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-553000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-15794000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-12502000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1374000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-5646000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1214000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	96000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	36830000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24542000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	16650000	usd
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	59555000	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	28372000	usd
CY2023Q1	vrns	Proceeds From Short Term And Long Term Deposits ProceedsFromShortTermAndLongTermDeposits	4000000	usd
CY2022Q1	vrns	Proceeds From Short Term And Long Term Deposits ProceedsFromShortTermAndLongTermDeposits	1850000	usd
CY2023Q1	vrns	Payments To Acquire Short Term And Long Term Deposits PaymentsToAcquireShortTermAndLongTermDeposits	102500000	usd
CY2022Q1	vrns	Payments To Acquire Short Term And Long Term Deposits PaymentsToAcquireShortTermAndLongTermDeposits	1853000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1110000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3495000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-142515000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31870000	usd
CY2023Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	5853000	usd
CY2022Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	6111000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	16864000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	28825000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2519000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13530000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-22714000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-119215000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30042000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	367800000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	805761000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	248585000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	775719000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	351000	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	507000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1608000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1582000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	997000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	248000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	42878000	usd
CY2023Q1	vrns	Contract With Customer Right Of Return Sales Returns ContractWithCustomerRightOfReturnSalesReturns	0	usd
CY2022	vrns	Contract With Customer Right Of Return Sales Returns ContractWithCustomerRightOfReturnSalesReturns	0	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P4Y
CY2023Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-300000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2961000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1414000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	162911000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	162911000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	278022000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	278022000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	55692000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9846000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	55993000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	65839000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	8831000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10650000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9731000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9502000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9708000	usd
CY2023Q1	vrns	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	23784000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	72206000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6367000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	65839000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y1M9D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0281
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	2292000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	2309000	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	463000	usd
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	100000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6110000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3704000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2406000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	381000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	381000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1143000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1263000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2406000	usd
CY2023Q1	vrns	Derivative Initial Cap Price DerivativeInitialCapPrice	47.24
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	691573	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.533
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	11347000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	39371	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.518
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	2100	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	7.192
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	650102	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.596
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	11971000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	645311	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.610
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	11874000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	776000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	136000	usd
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	650102	shares
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	7.596
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	645311	shares
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	7.610
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35811000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35998000	usd
CY2022Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000	usd
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	3014446	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	58964000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	41036000	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	107335000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	96261000	usd
CY2023Q1	us-gaap	Noncurrent Assets NoncurrentAssets	93335000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	95815000	usd

Files In Submission

Name	View Source	Status
0001628280-23-014872-index-headers.html	Edgar Link	pending
0001628280-23-014872-index.html	Edgar Link	pending
0001628280-23-014872.txt	Edgar Link	pending
0001628280-23-014872-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vrns-20230331.htm	Edgar Link	pending
vrns-20230331.xsd	Edgar Link	pending
vrnsq12023exh101.htm	Edgar Link	pending
vrnsq12023exh311.htm	Edgar Link	pending
vrnsq12023exh312.htm	Edgar Link	pending
vrnsq12023exh321.htm	Edgar Link	pending
vrnsq12023exh322.htm	Edgar Link	pending
vrns-20230331_cal.xml	Edgar Link	unprocessable
vrns-20230331_pre.xml	Edgar Link	unprocessable
vrns-20230331_def.xml	Edgar Link	unprocessable
vrns-20230331_lab.xml	Edgar Link	unprocessable
vrns-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VRNS
VARONIS SYSTEMS INC Stock $vrns

2023 Q2 Form 10-Q Financial Statement

#000162828023014872 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRNS VARONIS SYSTEMS INC Stock $vrns

2023 Q2 Form 10-Q Financial Statement

#000162828023014872 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRNS
VARONIS SYSTEMS INC Stock $vrns